Investigator-Initiated Preclinical studies at CIC biomaGUNE aimed at combatting Glioblastoma Multiforme Research will ...

Taylor Prater, our Faces off the field interview, enjoys Georgetown basketball's culture of excellence. This year's team ...

KOMZIFTI (ziftomenib), the first and only once-daily oral menin inhibitor for adult patients with R/R AML with a susceptible NPM1 mutation who have no satisfactory alternative treatment options, has ...

PythoC lets you use Python as a C code generator, but with more features and flexibility than Cython provides. Here’s a first ...

The Federal Reserve is widely expected to trim interest rates on Wednesday, but if Chair Jerome Powell wants to give markets ...

Amazon Q Developer is a useful AI-powered coding assistant with chat, CLI, Model Context Protocol and agent support, and AWS ...

Boeing has awarded $85,000 to ReMerge's FutureBound Workforce Readiness Initiative, which offers work certifications for high ...

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood ...

Discover how the Fed's end to quantitative tightening impacted markets and rate policy. Learn what this means for investors ...

The Illinois State Board of Education is developing a plan to change not just the way math is taught in the classroom, but ...

Expanded indication for AKEEGA® (niraparib and abiraterone acetate dual-action tablet) plus prednisone marks the first FDA-approved precision medicine ...

Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics, announced promising preclinical data from the company’s novel, ...